Ali Z, Yousaf N, Larkin J (2013) Melanoma epidemiology, biology and prognosis. EJC Suppl 11:81–91. https://doi.org/10.1016/j.ejcsup.2013.07.012
Article CAS PubMed PubMed Central Google Scholar
Bagheri H, Pourhanifeh MH, Derakhshan M et al (2020b) CXCL-10 a new candidate for melanoma therapy? Cell Oncol (dordr) 43:353–365. https://doi.org/10.1007/s13402-020-00501-z
Article CAS PubMed Google Scholar
Bi KW, Wei XG, Qin XX et al (2020) BTK has potential to be a prognostic factor for lung adenocarcinoma and an indicator for tumor microenvironment remodeling a study based on TCGA data mining. Front Oncol 10:424. https://doi.org/10.3389/fonc.2020.00424
Article PubMed PubMed Central Google Scholar
Bogani G, Tagliabue E, Signorelli M et al (2018) A score system for complete cytoreduction in selected recurrent ovarian cancer patients undergoing secondary cytoreductive surgery predictors- and nomogram-based analyses. J Gynecol Oncol 29:e40. https://doi.org/10.3802/jgo.2018.29.e40
Article PubMed PubMed Central Google Scholar
Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018 GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492
Carmeliet P, Jain RK (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473:298–307. https://doi.org/10.1038/nature10144
Article CAS PubMed PubMed Central Google Scholar
Carr S, Smith C, Wernberg J (2020) Epidemiology and risk factors of melanoma. Surg Clin North Am 100:1–12. https://doi.org/10.1016/j.suc.2019.09.005
Chen S, Liu Y, Yang J et al (2019) Development and validation of a nomogram for predicting survival in male patients with breast cancer. Front Oncol 9:361. https://doi.org/10.3389/fonc.2019.00361
Article CAS PubMed PubMed Central Google Scholar
Chen J, Huang L, Quan J et al (2021) TRIM14 regulates melanoma malignancy via PTEN/PI3K/AKT and STAT3 pathways. Aging (albany NY). 13:13225–13238. https://doi.org/10.18632/aging.203003
Article CAS PubMed PubMed Central Google Scholar
Cho WC, Jour G, Aung PP (2019) Role of angiogenesis in melanoma progression Update on key angiogenic mechanisms and other associated components. Semin Cancer Biol 59:175–186. https://doi.org/10.1016/j.semcancer.2019.06.015
Article CAS PubMed Google Scholar
Dewing D, Emmett M, Pritchard Jones R (2012) The roles of angiogenesis in malignant melanoma trends in basic science research over the last 100 years. ISRN Oncol. 2012:546927. https://doi.org/10.5402/2012/546927
Article CAS PubMed PubMed Central Google Scholar
Dvořánková B, Szabo P, Kodet O et al (2017) Intercellular crosstalk in human malignant melanoma. Protoplasma 254:1143–1150. https://doi.org/10.1007/s00709-016-1038-z
Article CAS PubMed Google Scholar
Emmett MS, Dewing D, Pritchard-Jones RO (2011a) Angiogenesis and melanoma - from basic science to clinical trials. Am J Cancer Res 1:852–868
CAS PubMed PubMed Central Google Scholar
Folkman J (1971) Tumor angiogenesis therapeutic implications. N Engl J Med 285:1182–1186. https://doi.org/10.1056/nejm197111182852108
Article CAS PubMed Google Scholar
Folkman J (2002) Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29:15–18. https://doi.org/10.1053/sonc.2002.37263
Article CAS PubMed Google Scholar
Gershenwald JE, Guy GP Jr (2016) Stemming the rising incidence of melanoma calling prevention to action. J Natl Cancer Inst. https://doi.org/10.1093/jnci/djv381
Article PubMed PubMed Central Google Scholar
Gong HZ, Zheng HY, Li J (2019b) Amelanotic melanoma. Melanoma Res 29:221–230. https://doi.org/10.1097/cmr.0000000000000571
Griss J, Bauer W, Wagner C et al (2019) B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma. Nat Commun 10:4186. https://doi.org/10.1038/s41467-019-12160-2
Article CAS PubMed PubMed Central Google Scholar
Huang R, Rofstad EK (2018) Integrins as therapeutic targets in the organ-specific metastasis of human malignant melanoma. J Exp Clin Cancer Res 37:92. https://doi.org/10.1186/s13046-018-0763-x
Article CAS PubMed PubMed Central Google Scholar
Huang R, Mao M, Lu Y et al (2020) A novel immune-related genes prognosis biomarker for melanoma associated with tumor microenvironment. Aging (albany NY) 12:6966–6980. https://doi.org/10.18632/aging.103054
Article CAS PubMed Google Scholar
Hugdahl E, Bachmann IM, Schuster C et al (2019) Prognostic value of uPAR expression and angiogenesis in primary and metastatic melanoma. PLoS ONE 14:e0210399. https://doi.org/10.1371/journal.pone.0210399
Article CAS PubMed PubMed Central Google Scholar
Jour G, Ivan D, Aung PP (2016) Angiogenesis in melanoma an update with a focus on current targeted therapies. J Clin Pathol 69:472–483. https://doi.org/10.1136/jclinpath-2015-203482
Article CAS PubMed Google Scholar
Kim HJ, Ji YR, Lee YM (2022) Crosstalk between angiogenesis and immune regulation in the tumor microenvironment. Arch Pharm Res 45:401–416. https://doi.org/10.1007/s12272-022-01389-z
Article CAS PubMed PubMed Central Google Scholar
Kobayashi M, Wakabayashi I, Suzuki Y et al (2021) Tubulin carboxypeptidase activity of vasohibin-1 inhibits angiogenesis by interfering with endocytosis and trafficking of pro-angiogenic factor receptors. Angiogenesis 24:159–176. https://doi.org/10.1007/s10456-020-09754-6
Article CAS PubMed Google Scholar
Kohler BA, Ward E, McCarthy BJ et al (2011) Annual report to the nation on the status of cancer, 1975–2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst 103:714–736. https://doi.org/10.1093/jnci/djr077
Article PubMed PubMed Central Google Scholar
Liu ZJ, Tian R, Li Y et al (2011) Inhibition of tumor angiogenesis and melanoma growth by targeting vascular E-selectin. Ann Surg 254:450–456. https://doi.org/10.1097/SLA.0b013e31822a72dc
Liu H, Qiu Y, Pei X et al (2020) Endothelial specific YY1 deletion restricts tumor angiogenesis and tumor growth. Sci Rep 10:20493. https://doi.org/10.1038/s41598-020-77568-z
Article CAS PubMed PubMed Central Google Scholar
Lovett M, Lee K, Edwards A et al (2009) Vascularization strategies for tissue engineering. Tissue Eng Part B Rev 15:353–370. https://doi.org/10.1089/ten.TEB.2009.0085
Article CAS PubMed PubMed Central Google Scholar
Marneros AG (2009) Tumor angiogenesis in melanoma. Hematol Oncol Clin North Am 23:431–446. https://doi.org/10.1016/j.hoc.2009.03.007
Oh DY, Fong L, Newell EW et al (2021) Toward a better understanding of T cells in cancer. Cancer Cell 39:1549–1552. https://doi.org/10.1016/j.ccell.2021.11.010
Article CAS PubMed Google Scholar
Olsen CM, Thompson JF, Pandeya N et al (2020) Evaluation of sex-specific incidence of melanoma. JAMA Dermatol 156:553–560. https://doi.org/10.1001/jamadermatol.2020.0470
Onetti Y, Kälin RE, Pitter B et al (2022) Deletion of endothelial α-parvin inhibits tumour angiogenesis, reduces tumour growth and induces tumour cell apoptosis. Angiogenesis 25:155–158. https://doi.org/10.1007/s10456-021-09829-y
Article CAS PubMed Google Scholar
Owen JL, Mohamadzadeh M (2013) Macrophages and chemokines as mediators of angiogenesis. Front Physiol 4:159. https://doi.org/10.3389/fphys.2013.00159
Article CAS PubMed PubMed Central Google Scholar
Rastrelli M, Tropea S, Rossi CR et al (2014) Melanoma epidemiology, risk factors, pathogenesis, diagnosis and classification. In Vivo 28:1005–1011
Ria R, Reale A, Castrovilli A et al (2010) Angiogenesis and progression in human melanoma. Dermatol Res Pract 2010:185687. https://doi.org/10.1155/2010/185687
Article CAS PubMed PubMed Central Google Scholar
Ribatti D, Vacca A, Dammacco F (1999) The role of the vascular phase in solid tumor growth a historical review. Neoplasia 1:293–302. https://doi.org/10.1038/sj.neo.7900038
留言 (0)